Press release


Berlin & Munich (DE) and Antwerp (BE), May 5, 2025, 07:30 CET



Gimv partners with Ambulantis to support the company's
growth ambitions
• Gimv invests in the German Ambulantis Group, a fast-growing care provider with a focus
on outpatient care in assisted living facilities and day care.
• The company currently employs more than 500 people and operates in 6 cities in
northern and eastern Germany, in some cases with multiple locations.
• This transaction is part of a growth plan with the company's founders and managing
directors, Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber, continuing to
be key shareholders of the company.

Ambulantis (www.ambulantis.de) is committed convinced that Ambulantis is the right platform
to enabling people in need of care to lead a to build a leading provider of comprehensive
fulfilling life in their own home or shared care services in assisted living facilities in
apartment. To this end, the company offers Germany. We are excited to supporting the
nursing care including outpatient care, day management and the entire Ambulantis team
care, care in assisted living facilities and in realizing their ambitious growth plans, ”
residential care communities. Its approach explain Philipp v. Hammerstein and Lars
enables customers to maintain a high degree Timmer, Partner and Senior Principal
of privacy and independence while benefiting specializing in healthcare in the Munich office
from nursing care tailored to their individual of Gimv.
needs. In addition, the Ambulantis concept
promotes social interaction and participation in Gimv will hold a significant stake in Ambulantis
society through numerous joint activities. and will support Dr. Stefan Buchkremer, Richard
Simm and Dr. Matthias Weber in the further
Ambulantis fosters a value-oriented corporate development of the group. The transaction is
culture based on appreciation, care and still subject to the usual regulatory approval
participation. The intensive and diverse and is expected to be completed in the
engagement of the company's employees coming weeks.
leads to a high level of employee satisfaction
across all locations.

“We are convinced that Gimv's experience in
building and scaling healthcare providers
makes it the ideal partner to help us realize the
company's growth ambitions and expand
Ambulantis' presence in Germany,” declare Dr.
Stefan Buchkremer, Richard Simm and Dr.
Matthias Weber, Managing Partners of
Ambulantis.

“Ambulantis has a focused and proven
concept that serves the preferences of clients
and relatives as well as caregivers. Thanks to
Ambulantis' clear commitment to quality, its
skilled and motivated staff and its highly
structured and scalable processes, we are




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 1
Berlin & Munich (DE) and Antwerp (BE), May 5, 2025, 07:30 CET

Press release




About Gimv

Gimv is a European investment company, listed
on Euronext Brussels and a member of the
Euronext BEL ESG Index. With over 40 years'
experience in private equity, Gimv currently has
an investment portfolio of more than EUR 1.7
billion. The portfolio contains around 60 portfolio
companies, with combined turnover of EUR 4.0
billion and more than 20,000 employees.

As a recognized market leader in selected
investment platforms, Gimv identifies
entrepreneurial, innovative companies with high
growth potential and supports them in their
transformation into market leaders. Gimv's five
investment platforms are Consumer, Healthcare,
Life Sciences, Smart Industries and Sustainable
Cities. Each platform works with an experienced
team across Gimv’s home markets of Benelux,
France and DACH, supported by an extended
international network of experts.

Further information on Gimv can be found on
www.gimv.com.

For further information please contact:

Philipp v. Hammerstein, Partner Healthcare
T +49 89 44 23 275 10
philipp.hammerstein@gimv.com

Kristof Vande Capelle, CFO
T +32 3 290 22 17
kristof.vandecapelle@gimv.com




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 2